Gino Biotech

Gino Biotech is a clinical-stage biopharmaceutical company based in China that focuses on the discovery and development of innovative therapies for oncology and other high-unmet-need therapeutic areas. The company maintains a diverse pipeline of small molecule inhibitors and biologics designed to target key pathways in cancer progression, including angiogenesis and immune evasion. Gino Biotech leverages its internal R&D capabilities to advance candidates from early discovery through clinical validation. Its lead programs are currently undergoing clinical trials in China, aiming to provide more effective treatment options for patients with solid tumors.